Pharmacogenetics in drug regulation: promise, potential and pitfalls.
about
Animal models and conserved processesCytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Introduction: genetic variation and human healthPharmacogenetics of Drug-Induced QT Interval Prolongation: An UpdateCan pharmacogenetics help rescue drugs withdrawn from the market?Pharmacogenomics of beta2-agonist: key focus on signaling pathways.Development of a novel, fully-automated genotyping system: principle and applications.Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.Routine pharmacogenetic testing in clinical practice: dream or reality?Pharmacogenetics and stroke.HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.(13)C breath tests in personalized medicine: fiction or reality?Personalized therapy in pain management: where do we stand?Do we need pharmacogenetics to personalize antidepressant therapy?Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin.N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study.Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.Pathogenesis of thrombosis: cellular and pharmacogenetic contributions.Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration.
P2860
Q28710144-6413A906-F2E3-4D0C-9911-305EDECF80EEQ34491448-E3FAA790-7C70-4BE3-80BE-55250CCE72D7Q35038060-17FA2086-CDF0-4F8C-9124-1029238E90A8Q36084069-383F4777-9930-4C75-9CA7-3E39E2153E89Q36596713-61DEE873-9DFB-4C4A-8EEA-E3262613DF27Q36596722-09369CC5-ECA0-418F-AEEF-13B7E962F2CCQ36608218-C8063ACB-CE48-4212-A437-F4595B3858FEQ36874335-79FDBBFD-FEA6-4B2F-BA24-A600F8B22217Q36897732-22D0A6DE-D307-475A-BC20-A88741C68C8EQ36989859-D8172AF0-C685-4545-9D1E-7F6036EDE242Q37425335-3FA67C28-FDC7-4B1D-AAA3-B54011DF9055Q37514235-8244B6E3-9025-4AF0-81F0-F045E48F711AQ37628680-70DCA1B0-4879-4671-8A0E-7237873384B2Q37760955-7FB89D11-D88F-456E-814D-694930DD40C5Q38070163-C5063A26-F35F-453B-A841-6C4605772CC4Q38091648-8C53601B-253D-44B7-A11B-AFB5EED59413Q38113093-0AB0A8C4-529C-4FD7-95F6-B7FE0924C056Q41674917-A8625CB4-DC13-436C-8049-2D1077B9A604Q42324494-21221945-6E75-4D4C-87D6-69142C6386F0Q49332587-30E3DFB8-2C68-454A-878B-B6C59D9685A1Q51762742-6F7FD7E4-9799-44C1-8E6D-94547B1EA9F0
P2860
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@ast
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@en
type
label
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@ast
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@en
prefLabel
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@ast
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@en
P2860
P356
P1476
Pharmacogenetics in drug regulation: promise, potential and pitfalls.
@en
P2093
Rashmi R Shah
P2860
P304
P356
10.1098/RSTB.2005.1693
P407
P577
2005-08-01T00:00:00Z